Free Trial
→ America’s AI Doomsday Scenario (From Weiss Ratings) (Ad)tc pixel
OTCMKTS:HYPMY

Hypermarcas Q4 2024 Earnings Results & Report

Hypermarcas logo
$5.30 0.00 (0.00%)
As of 10/9/2026 09:45 AM Eastern

Hypermarcas reported Q4 2024 earnings on March 20, 2025. The company reported EPS of $0.02, while revenue was $258.56 million.

Research:ProfileEarnings HistoryForecast

Earnings Announcement Details

Quarter
Q4 2024
Report Date
Time
Before Market Opens

Hypermarcas EPS Results

Actual EPS
$0.02
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Hypermarcas Revenue Results

Actual Revenue
$258.56 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Upcoming Earnings

Hypermarcas' next earnings date is estimated for Wednesday, November 11, 2026, based on past reporting schedules.

Conference Call Resources

Hypermarcas Q4 2024 Earnings FAQ

Hypermarcas (OTCMKTS:HYPMY) reported earnings of $0.02 per share for Q4 2024. The report was announced on Thursday, March 20, 2025.

Hypermarcas reported revenue of $258.56 million for Q4 2024.

Hypermarcas' next earnings date is estimated for Wednesday, November 11, 2026. MarketBeat tracks confirmed and estimated earnings dates for Hypermarcas on the company's earnings history page.

Hypermarcas Earnings Headlines

Hypermarcas (OTCMKTS:HYPMY) Sees Unusually-High Trading Volume - Should You Buy?
October 6, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31092953
Hypermarcas (OTCMKTS:HYPMY) Reaches New 12-Month High - Should You Buy?
October 5, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31087455
Palantir and Wall Street are in on it…
Palantir just signed a major AI deal with a company most investors have never heard of. Wall Street has poured billions into this firm, which may have found a solution to the growing AI energy crunch. Unlike pricey chipmakers trading at 40 times earnings, this pure-play AI energy name remains cheap and profitable. See the name and ticker behind this fast-moving story before wider attention catches on.tc pixel
October 12 at 1:00 AM  |  Monument Traders Alliance (Ad)
Head to Head Comparison: NRx Pharmaceuticals (NASDAQ:NRXP) & Hypermarcas (OTCMKTS:HYPMY)
October 5, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31086043
Hypera ON ADR (HYPMY)
September 27, 2026  |  es.investing.comhttps://es.investing.com/equities/hypermarcas-sa-news
Hypera S.A. (HYPMY) Q2 2026 Earnings Call Transcript
August 11, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4934927-hypera-s-a-hypmy-q2-2026-earnings-call-transcript
See More Hypermarcas Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Hypermarcas? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Hypermarcas and other key companies, straight to your email.

About Hypermarcas

Hypermarcas (OTCMKTS:HYPMY) S.A. was a Brazilian consumer healthcare company that developed, manufactured and marketed pharmaceutical and healthcare products. Its portfolio included over-the-counter medicines, prescription products, vitamins and other consumer health brands sold through pharmacies and retail channels.

The company was historically associated with well-known Brazilian brands such as Benegrip, Biotônico Fontoura, Doril, Engov and Epocler. Hypermarcas also previously operated in personal care, beauty, household cleaning and other consumer categories, but divested many of those businesses as it concentrated on pharmaceuticals and healthcare.

In 2018, Hypermarcas changed its corporate name to Hypera S.A., adopting the Hypera Pharma identity. The company’s principal market has been Brazil, with its operations focused on serving the Brazilian healthcare and pharmaceutical market.

View Hypermarcas Profile
Earnings Tools